Amgen Inc. vs Merck & Company, Inc. — Stock Comparison
Amgen Inc. (AMGN) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merck & Company, Inc. narrowly edges Amgen Inc. on Q·Score (6.9 vs 6.7 out of 10), led by Health (7 vs 4.5) and Sentiment (7.1 vs 5.6). Amgen Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for MRK (+9.0%) than for AMGN (-0.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 101% return on equity and 21% profit margins.
⚠ high leverage at 6.2× debt-to-equity.
High-quality business with 19% return on equity and 14% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
AMGN vs MRK: which stock scores better overall?
Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.9/10 versus Amgen Inc. (AMGN) at 6.7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: AMGN or MRK?
Amgen Inc. (AMGN) scores higher on Growth (6.3/10 vs 6.2/10). Amgen Inc. reports revenue growth (5.8% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is AMGN or MRK more attractively valued?
Amgen Inc. (AMGN) scores higher on Valuation (6.8/10 vs 6.4/10). AMGN trades at 15.1× P/E versus MRK at 12.4×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about AMGN vs MRK?
There are 30 analysts covering AMGN with a consensus price target of $352.50, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: AMGN or MRK?
Amgen Inc. (AMGN) scores higher on Quality (9.3/10 vs 7.7/10). Net profit margin: AMGN at 21.0%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: AMGN or MRK?
Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 4.5/10). Market beta: AMGN at 0.42, MRK at 0.22. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of AMGN and MRK?
Amgen Inc. (AMGN) has a market capitalisation of $191.7B, while Merck & Company, Inc. (MRK) has a market cap of $294.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do AMGN or MRK pay dividends?
AMGN pays a dividend yield of 2.84%, while MRK pays a dividend yield of 2.86%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →